ATE262529T1 - Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dih dro-1h-pyrrolizin-5- yl-essigsäure - Google Patents

Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dih dro-1h-pyrrolizin-5- yl-essigsäure

Info

Publication number
ATE262529T1
ATE262529T1 AT01905691T AT01905691T ATE262529T1 AT E262529 T1 ATE262529 T1 AT E262529T1 AT 01905691 T AT01905691 T AT 01905691T AT 01905691 T AT01905691 T AT 01905691T AT E262529 T1 ATE262529 T1 AT E262529T1
Authority
AT
Austria
Prior art keywords
compound
pyrrolizine
chlorphenyl
dimethyl
phenyl
Prior art date
Application number
AT01905691T
Other languages
English (en)
Inventor
Thomas Kammermeier
Stefan Laufer
Philipp Merckle
Hans-Guenter Striegel
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MXPA/A/2000/001047A external-priority patent/MXPA00001047A/xx
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Application granted granted Critical
Publication of ATE262529T1 publication Critical patent/ATE262529T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT01905691T 2000-01-28 2001-01-26 Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dih dro-1h-pyrrolizin-5- yl-essigsäure ATE262529T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA/A/2000/001047A MXPA00001047A (en) 2000-01-28 Method for producing 6-(4-chlorophenyl) -2,2-dimethyl-7- phenyl -2,3-dihydro- 1h-pyrrolizine- 5-yl acetic acid

Publications (1)

Publication Number Publication Date
ATE262529T1 true ATE262529T1 (de) 2004-04-15

Family

ID=32589023

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01905691T ATE262529T1 (de) 2000-01-28 2001-01-26 Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dih dro-1h-pyrrolizin-5- yl-essigsäure

Country Status (31)

Country Link
US (1) US6417371B1 (de)
EP (1) EP1252164B1 (de)
JP (1) JP5143326B2 (de)
KR (1) KR100749222B1 (de)
CN (1) CN1160357C (de)
AT (1) ATE262529T1 (de)
AU (1) AU779616B2 (de)
BG (1) BG65567B1 (de)
BR (1) BR0107898A (de)
CA (1) CA2397767C (de)
CU (1) CU23193A3 (de)
DE (1) DE50101761D1 (de)
DK (1) DK1252164T3 (de)
EA (1) EA004938B1 (de)
EE (1) EE05125B1 (de)
ES (1) ES2218382T3 (de)
GE (1) GEP20043408B (de)
HK (1) HK1047590A1 (de)
HR (1) HRP20020707B1 (de)
HU (1) HUP0300604A3 (de)
IS (1) IS2404B (de)
NZ (1) NZ520429A (de)
PL (1) PL208027B1 (de)
PT (1) PT1252164E (de)
RS (1) RS50374B (de)
SK (1) SK286608B6 (de)
TR (1) TR200400691T4 (de)
TW (1) TWI289561B (de)
UA (1) UA72580C2 (de)
WO (1) WO2001055149A1 (de)
ZA (1) ZA200206832B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141285A1 (de) * 2001-08-23 2003-03-27 Merckle Gmbh Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
DE102005012971A1 (de) * 2005-03-21 2006-09-28 Merckle Gmbh Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
WO2007108006A1 (en) * 2006-03-23 2007-09-27 Unichem Laboratories Limited Process for the preparation of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2, 3-dihydro-1h-pyrrolizin-5-yl acetic acid and its intermediates
WO2010049525A1 (en) * 2008-10-31 2010-05-06 C-A-I-R Biosciences Gmbh Choline and tromethamine salt of licofelone
EP3324959B1 (de) * 2015-07-17 2023-07-12 The Board Of Regents Of The University Of Oklahoma Licofelonderivate und verfahren zur verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3915450A1 (de) * 1989-05-11 1990-11-15 Gerd Prof Dr Dannhardt Substituierte pyrrolverbindungen und deren anwendung in der pharmazie
US5260451A (en) 1989-05-11 1993-11-09 Merckle Gmbh Substituted pyrrole compounds and use thereof in pharmaceutical compositions
DE4419247A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
DE4419315A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419246A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie

Also Published As

Publication number Publication date
TWI289561B (en) 2007-11-11
PT1252164E (pt) 2004-08-31
HRP20020707B1 (en) 2006-05-31
CN1396922A (zh) 2003-02-12
CU23193A3 (es) 2007-03-23
PL208027B1 (pl) 2011-03-31
WO2001055149A1 (de) 2001-08-02
EP1252164B1 (de) 2004-03-24
IS6475A (is) 2002-07-19
ZA200206832B (en) 2003-10-07
EE200200417A (et) 2003-12-15
PL356774A1 (en) 2004-07-12
US20020028953A1 (en) 2002-03-07
GEP20043408B (en) 2004-06-10
EP1252164A1 (de) 2002-10-30
YU56502A (sh) 2005-06-10
CA2397767A1 (en) 2001-08-02
DK1252164T3 (da) 2004-07-05
BG106951A (en) 2003-07-31
SK286608B6 (sk) 2009-02-05
AU779616B2 (en) 2005-02-03
EE05125B1 (et) 2009-02-16
SK10432002A3 (sk) 2003-02-04
HK1047590A1 (en) 2003-02-28
AU3371101A (en) 2001-08-07
TR200400691T4 (tr) 2004-11-22
HUP0300604A2 (hu) 2003-07-28
BG65567B1 (bg) 2008-12-30
HRP20020707A2 (en) 2004-12-31
DE50101761D1 (de) 2004-04-29
UA72580C2 (en) 2005-03-15
EA200200740A1 (ru) 2002-12-26
JP5143326B2 (ja) 2013-02-13
RS50374B (sr) 2009-11-10
EA004938B1 (ru) 2004-10-28
CA2397767C (en) 2008-05-06
JP2004517799A (ja) 2004-06-17
HUP0300604A3 (en) 2003-10-28
IS2404B (is) 2008-09-15
ES2218382T3 (es) 2004-11-16
KR20020075895A (ko) 2002-10-07
CN1160357C (zh) 2004-08-04
KR100749222B1 (ko) 2007-08-13
US6417371B1 (en) 2002-07-09
NZ520429A (en) 2003-08-29
BR0107898A (pt) 2002-11-05

Similar Documents

Publication Publication Date Title
ATE477238T1 (de) Verfahren zur herstellung von dithioestern
ATE366725T1 (de) Verfahren zur herstellung von gereinigten 1,3- substituierten imidazoliumsalzen
ATE478084T1 (de) Verfahren zur herstellung von 4'- azidocytidinderivaten
DE60135658D1 (de) In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung
ATE398628T1 (de) Oxidationsverfahren zur herstellung des zwischenproduktes 6.alpha.,9.alpha.-difluoro-
ATE262529T1 (de) Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dih dro-1h-pyrrolizin-5- yl-essigsäure
ATE488492T1 (de) Verfahren zur herstellung von gabapentin
ATE250057T1 (de) Verfahren zur herstellung von 1-(1h)- benzoquinolizin-3-on derivaten
ATE302749T1 (de) Verfahren zur herstellung von 5-aminosalicylsäure
ATE329900T1 (de) Verfahren zur herstellung von 2-pyrrolidon
ATE317259T1 (de) Verfahren zur herstellung fester formulierungen von natrium-3-hydroxy-3-methylbutyrat
MY128460A (en) Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
ATE473213T1 (de) Verfahren zur herstellung von phenyl-2- pyrimidinyl-ketonen und neuen zwischenprodukten daraus
ATE299862T1 (de) Verfahren zur herstellung von ketiminen
ATE425972T1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
ATE277886T1 (de) Verfahren zur herstellung von serinol
DE69914493D1 (de) Verfahren zur herstellung von 2-hydroxy-6-trifluormethylpyridin
ATE330932T1 (de) Verfahren zur herstellung von 3- aminoalkansäureestern
ATE240289T1 (de) Verfahren zur herstellung fliessfähiger, konzentrierter betainlösungen
ATE387436T1 (de) Verfahren zur herstellung von isoflavonen
ATE260883T1 (de) Verfahren zur herstellung von atropasäureethylester
DE50112461D1 (de) Verfahren zur herstellung von n-substituierten hydroxylaminen und deren salzen
ATE236135T1 (de) Verfahren zur herstellung von 4,6- dichlorpyrimidin
ATE321028T1 (de) Verfahren zur herstellung von 1,3- disubstituierten 2-nitroguanidinen
JP2000198758A (ja) ヒドロキシウンデカン酸の脱臭方法